{"id":5978,"date":"2025-03-20T12:52:21","date_gmt":"2025-03-20T17:52:21","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5978"},"modified":"2025-07-13T15:10:24","modified_gmt":"2025-07-13T20:10:24","slug":"nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30a2\u30c7\u30e2\u30e9\u30fb\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u3092\u54c1\u8cea\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u62c5\u5f53\u526f\u793e\u9577\u306b\u4efb\u547d\u3057\u305f\u3053\u3068\u3092\u767a\u8868"},"content":{"rendered":"
\n
\n
\n
\n
\n

<\/h1>\n<\/div>\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02025\u5e743\u670820\u65e5<\/span><\/span>\u00a0 \u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u3057\u3044\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u958b\u767a\u3068\u5546\u54c1\u5316\u3092\u901a\u3058\u3066\u3001\u73fe\u5b9f\u4e16\u754c\u3067\u5931\u660e\u3057\u305f\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u00a0\u30a2\u30c7\u30e2\u30e9\u30fb\u30c0\u30e9\u30e2\u30e9<\/span>\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u3001\u54c1\u8cea\u304a\u3088\u3073\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u62c5\u5f53\u526f\u793e\u9577\u3068\u3057\u3066\u5f53\u793e\u306b\u5165\u793e\u3057\u307e\u3057\u305f\u3002\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u3001\u30d2\u30c8\u7528\u533b\u85ac\u54c1\u3001\u30ef\u30af\u30c1\u30f3\u3001\u533b\u7642\u6a5f\u5668\u306e\u5e45\u5e83\u3044\u54c1\u8cea\u4fdd\u8a3c\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3001\u904b\u7528\u306e\u5353\u8d8a\u6027\u306b\u95a2\u3059\u308b\u30d7\u30ed\u30bb\u30b9\u306e\u958b\u767a\u3068\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306e\u7ba1\u7406\u306b\u304a\u3044\u3066 20 \u5e74\u4ee5\u4e0a\u306e\u7d4c\u9a13\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u201c\u300c\u30a2\u30c7\u30e2\u30e9\u6c0f\u306f\u3001\u3055\u307e\u3056\u307e\u306a\u6a5f\u80fd\u306b\u308f\u305f\u308b\u54c1\u8cea\u4fdd\u8a3c\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306b\u304a\u3044\u3066\u512a\u308c\u305f\u30ea\u30fc\u30c0\u30fc\u3067\u3042\u308a\u3001FDA\u3092\u542b\u3080\u88fd\u85ac\u696d\u754c\u3067\u306e\u8c4a\u5bcc\u306a\u7d4c\u9a13\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4<\/span>, \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u5171\u540c\u5275\u696d\u8005\u517cCEO\u3067\u3042\u308b\u5f7c\u306f\u3001\u300c\u5f7c\u306e\u5c02\u9580\u77e5\u8b58\u306f\u3001\u5f53\u793e\u304c\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u306e\u5546\u696d\u5316\u306b\u5411\u3051\u3066\u524d\u9032\u3057\u3066\u3044\u304f\u4e0a\u3067\u975e\u5e38\u306b\u8cb4\u91cd\u306a\u3082\u306e\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u300d\u3068\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u201c<\/p>\n

\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u3001\u88fd\u85ac\u304a\u3088\u3073\u533b\u7642\u6a5f\u5668\u696d\u754c\u306b\u304a\u3051\u308b\u5e45\u5e83\u3044\u54c1\u8cea\u4fdd\u8a3c\u304a\u3088\u3073\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u30af\u30ed\u30b9\u30d5\u30a1\u30f3\u30af\u30b7\u30e7\u30ca\u30eb\u30c1\u30fc\u30e0\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3001\u30d7\u30ed\u30bb\u30b9\u306e\u958b\u767a\u3001\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306e\u7ba1\u7406\u306b\u304a\u3044\u3066\u8c4a\u5bcc\u306a\u7d4c\u9a13\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u76f4\u8fd1\u3067\u306f\u3001\u30d3\u30eb\uff06\u30e1\u30ea\u30f3\u30c0\u30fb\u30b2\u30a4\u30c4\u533b\u5b66\u7814\u7a76\u6240\u306eGMP\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u30ea\u30fc\u30c0\u30fc\u3092\u52d9\u3081\u3001\u7b2c\u4e09\u8005\u65bd\u8a2d\u3067\u88fd\u9020\u3055\u308c\u308b\u30b2\u30a4\u30c4MRI\u306e\u751f\u7269\u88fd\u5264\u3001\u30ef\u30af\u30c1\u30f3\u3001\u4f4e\u5206\u5b50\u533b\u85ac\u54c1\u304c\u3001\u5fc5\u8981\u306a\u54c1\u8cea\u304a\u3088\u3073\u5b89\u5168\u898f\u5236\u306b\u6e96\u62e0\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u4fdd\u8a3c\u3059\u308b\u8cac\u4efb\u3092\u8ca0\u3063\u3066\u3044\u307e\u3057\u305f\u3002\u305d\u308c\u4ee5\u524d\u306f\u3001CIPLA\u306e\u526f\u793e\u9577\u517c\u30b0\u30ed\u30fc\u30d0\u30eb\u54c1\u8cea\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u8cac\u4efb\u8005\u3067\u3057\u305f\u3002\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u3001FDA\u3067\u56fd\u969b\u95a2\u4fc2\u30b9\u30da\u30b7\u30e3\u30ea\u30b9\u30c8\u304a\u3088\u3073\u533b\u85ac\u54c1\u30fb\u533b\u7642\u6a5f\u5668\u306e\u6d88\u8cbb\u8005\u5b89\u5168\u62c5\u5f53\u5b98\u3068\u3057\u3066\u7d048\u5e74\u9593\u52e4\u52d9\u3057\u307e\u3057\u305f\u3002\u30ad\u30e3\u30ea\u30a2\u306f\u3001\u30c6\u30d0\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u306e\u5316\u5b66\u8005\u3068\u3057\u3066\u30b9\u30bf\u30fc\u30c8\u3057\u307e\u3057\u305f\u3002\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u30d8\u30eb\u30b9\u5206\u91ce\u3067\u535a\u58eb\u53f7\u3068\u4fee\u58eb\u53f7\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u00a0\u30ce\u30d0\u30b5\u30a6\u30b9\u30a4\u30fc\u30b9\u30bf\u30f3\u5927\u5b66<\/span>\u5f7c\u306f\u5de5\u5b66\u58eb\u306e\u5b66\u4f4d\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u00a0\u30d0\u30ea\u30fc\u5927\u5b66<\/span>\u30aa\u30f3\u30c9\u5dde\u7acb\u5927\u5b66\u3067\u7406\u5b66\u58eb\u53f7\u3092\u53d6\u5f97\u3002\u00a0\u30ca\u30a4\u30b8\u30a7\u30ea\u30a2<\/span>.<\/p>\n

\u201c\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306f\u3001\u4f01\u696d\u3068\u3057\u3066\u306e\u6210\u9577\u3068\u3001\u4e3b\u8981\u5019\u88dc\u85ac\u3067\u3042\u308bMCO-010\u306e\u958b\u767a\u306e\u4e21\u9762\u306b\u304a\u3044\u3066\u3001\u91cd\u8981\u306a\u8ee2\u63db\u671f\u3092\u8fce\u3048\u3066\u3044\u307e\u3059\u300d\u3068\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u3053\u306e\u6d3b\u6c17\u306b\u6e80\u3061\u305f\u6709\u80fd\u306a\u30c1\u30fc\u30e0\u3068\u5354\u529b\u3067\u304d\u308b\u3053\u3068\u3092\u5927\u5909\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u305d\u3057\u3066\u3001\u3053\u308c\u3089\u306e\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u60a3\u8005\u3055\u3093\u306b\u5c4a\u3051\u308b\u306b\u3042\u305f\u308a\u3001\u6700\u9ad8\u6c34\u6e96\u306e\u54c1\u8cea\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3067\u304d\u308b\u3088\u3046\u5c3d\u529b\u3057\u3066\u307e\u3044\u308a\u307e\u3059\u3002\u300d\u201d<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002RESTORE\u30d5\u30a7\u30fc\u30ba\u306e\u8a66\u9a13\u7d42\u4e86\u6642\u306b\u826f\u597d\u306a\u7d50\u679c\u304c\u5f97\u3089\u308c\u305f\u3053\u3068\u3092\u53d7\u3051\u3066\u3001\u00a02b<\/span>\u00a0RP\u306b\u5bfe\u3059\u308b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a0\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u3001\u540c\u3058\u304f2025\u5e74\u4e0a\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001IND\u5bfe\u5fdc\u306eGA\u5411\u3051\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u8cc7\u7523\u3068\u3001IND\u5bfe\u5fdc\u7814\u7a76\u4e2d\u306eLeber\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051AAV\u8cc7\u7523\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0March 20, 2025\u00a0 \u2014 Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced that\u00a0Ademola Daramola, D.Sc., has joined the company as Vice President, Quality and Compliance. Dr. Daramola has more than two decades of experience developing processes and managing workflows for a wide range of quality assurance, compliance and operational excellence\u00a0in human drugs, vaccines and medical devices. \u201cAdemola is an accomplished\u00a0leader in quality assurance and compliance across different functions,\u00a0with deep experience in the pharmaceutical industry, including with the FDA,\u201d said\u00a0Sulagna Bhattacharya, co-founder and CEO of Nanoscope. \u201cHis expertise will be […]<\/p>\n","protected":false},"author":6,"featured_media":5979,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-20T17:52:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:10:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance\",\"datePublished\":\"2025-03-20T17:52:21+00:00\",\"dateModified\":\"2025-07-13T20:10:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/\"},\"wordCount\":502,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_AdeDaramola_V1_REV2.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/\",\"name\":\"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_AdeDaramola_V1_REV2.jpg\",\"datePublished\":\"2025-03-20T17:52:21+00:00\",\"dateModified\":\"2025-07-13T20:10:24+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_AdeDaramola_V1_REV2.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_AdeDaramola_V1_REV2.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/20\\\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30a2\u30c7\u30e2\u30e9\u30fb\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u3092\u54c1\u8cea\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u62c5\u5f53\u526f\u793e\u9577\u306b\u4efb\u547d - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-03-20T17:52:21+00:00","article_modified_time":"2025-07-13T20:10:24+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance","datePublished":"2025-03-20T17:52:21+00:00","dateModified":"2025-07-13T20:10:24+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/"},"wordCount":502,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/","url":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30a2\u30c7\u30e2\u30e9\u30fb\u30c0\u30e9\u30e2\u30e9\u535a\u58eb\u3092\u54c1\u8cea\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u62c5\u5f53\u526f\u793e\u9577\u306b\u4efb\u547d - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","datePublished":"2025-03-20T17:52:21+00:00","dateModified":"2025-07-13T20:10:24+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_AdeDaramola_V1_REV2.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/20\/nanoscope-therapeutics-announces-the-appointment-of-ademola-daramola-d-sc-as-vice-president-quality-compliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces the Appointment of Ademola Daramola, D.Sc., as Vice President, Quality & Compliance"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5978"}],"version-history":[{"count":3,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5978\/revisions"}],"predecessor-version":[{"id":7221,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5978\/revisions\/7221"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5979"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}